Moreover, disulfiram-sunitinib cotreatment induced apoptosis whereas neither of the compounds alone promoted programmed cell death in TMPRSS2-ERG fusion positive VCaP prostate cancer cells. Here, TMPRSS2 is linked to prostate carcinoma.